Avelox (moxifloxacin) is a fluoroquinolone antibiotic that is used to treat bacterial infections, including bronchitis, sinusitis, pneumonia, tuberculosis, anthrax, skin infections, and more. It was developed by Bayer AG and approved for sale in the U.S. in 1999. In 2011, over 2.5 million people were given oral or intravenous (IV) Avelox.
Related Tags of Avelox
Avelox lawsuit, peripheral neuropathy, nerve damage, chronic nerve pain, muscle weakness, numbness, Avelox lawyer, Avelox attorney